Displaying 1 - 12 of 17
Metabolism, Alcohol & Toxicity

Novo Nordisk and Echosens: "Clinical challenge: Updates on the non-invasive toolbox for NASH and Fibrosis" (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity
Wrap-up

Wrap-up

Webcasts
View
Metabolism, Alcohol & Toxicity
Introduction

Introduction

Webcasts
View
Metabolism, Alcohol & Toxicity
Q&A

Q&A

Webcasts
View
Metabolism, Alcohol & Toxicity
Agile 3+ and Agile 4: two new scores to better identify advanced fibrosis and cirrhosis in NAFLD patients

Agile 3+ and Agile 4: two new scores to better identify advanced fibrosis and cirrhosis in NAFLD patients

Webcasts
View
Metabolism, Alcohol & Toxicity
Clinical cases presentation and discussion

Clinical cases presentation and discussion

Webcasts
View
Metabolism, Alcohol & Toxicity
FAST score for identification of active fibrotic NASH

FAST score for identification of active fibrotic NASH

Webcasts
View
Cirrhosis & Complications
Meeting the challenge of severe thrombocytopenia with TPO-RAs

Meeting the challenge of severe thrombocytopenia with TPO-RAs

Webcasts
View
Cirrhosis & Complications
Pathways and service redesign – successfully integrating TPO-RAs into clinical practice

Pathways and service redesign – successfully integrating TPO-RAs into clinical practice

Webcasts
View
Cirrhosis & Complications
Evidence from the field and practical advantages of TPO-RAs

Evidence from the field and practical advantages of TPO-RAs

Webcasts
View
Cirrhosis & Complications
Welcome & Introduction

Welcome & Introduction

Webcasts
View
Cirrhosis & Complications

Welcome and introduction

Webcasts
View
Displaying 1 - 12 of 17